Ultimo aggiornamento :
19/11/2024
Vasodilatatore   Papaverine hydrochloride  
Iniezione
Stabilità in soluzione Stabilità in miscela Fattori che influenzano la stabilità Compatibilità metodo di iniezione Bibliografia pdf
   Struttura chimica  

Nome commerciale   Nome commerciale     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

DBL papaverine hydrochloride nuova Zelanda
Papaverin Recip Svezia
Papaverine chlorhydrate Francia, Malaysia
Bibliografia   Iniezione   Bibliografia : Papaverine hydrochloride  
tipo pubblicazione
456 Rivista Tu YH, Allen LV, Wang DP.
Stability of papaverine hydrochloride and phentolamine mesylate in injectable mixtures.
Am J Hosp Pharm 1987 ; 44: 2524-2527.
939 Rivista Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1085 Rivista Irving HD, Burbridge BE.
Incompatibility of contrast agents with intravascular medications.
Radiology 1989 ; 173: 91-92.
1899 Rivista Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2150 Rivista Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
3448 Rivista Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Ann Pharm Fr 2013 ; 71, 5: 358-363.

  Mentions Légales